NCT01615250

Implantation of Peripheral Stem Cells in Patient With Ischemic Cardiomyopathy

Phase I Study to Evaluate the Efficacy and Safety of Intramyocardial Implantation of Peripheral Mononuclear Cells With CD34+ Stem Cells in Patient With Ischemic Cardiomyopathy After Preparatory Course of Shock - Wave Therapy

• Status: Unknown
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 50 (estimated)
• Sponsor: Odessa National Medical University · Academic / Other
• Sex: All
• Age: 20 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

This is a randomized study of efficiency and safety of intramyocardial implantation of peripheral mononuclear cells with high concentration of CD34+ stem cells in patients with myocardial ischemia after preparatory course of shock - wave therapy.

Conditions

• Heart Failure

Interventions

Type	Name	Description
BIOLOGICAL	Intramyocardial implantation of stem cells	Intramyocardial implantation of autologous peripheral mononuclear cells with CD34+ stem cells by NOGA.XP navigation system. Сell concentration is 200 million cells in 1 ml.

Timeline

• Start date: 2012-01-01
• Primary completion: 2015-01-01
• Completion: 2016-01-01
• First posted: 2012-06-08
• Last updated: 2012-06-11

Locations

1 site across 1 country: Ukraine